MedPath

Efficacy of Proactive Telephone Counseling for Pregnant Smokers Enrolled in a Managed Care Organization

Phase 3
Completed
Conditions
Pregnancy
Smoking Cessation
Registration Number
NCT00181909
Lead Sponsor
Massachusetts General Hospital
Brief Summary

The principal objective is to test whether offering pregnant smokers a proactive telephone counseling program throughout pregnancy and for 2 months postpartum increases the rate of smoking cessation at end of pregnancy and 3 months postpartum, compared to a "best practice" control condition.

Detailed Description

A randomized controlled trial compared the efficacy of a proactive pregnancy-tailored telephone-delivered smoking cessation counseling program with a "best practice" brief counseling control condition among pregnant women referred by prenatal care providers and a managed care plan in Massachusetts. Intervention group patients received up to 105 min of cognitive-behavioral counseling delivered in a motivational interviewing style by trained counselors throughout pregnancy and for 2 months postpartum. Control group patients received 5 minutes of brief counseling at 1 telephone call. All participants were mailed written self-help smoking cessation material tailored to pregnancy. The primary outcome measure was cotinine-validated tobacco abstinence at the end of pregnancy. Secondary outcomes were cotinine-validated abstinence at 3 months postpartum and self-reported significant (\>50%) reduction in daily cigarette use.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
434
Inclusion Criteria
  • Pregnant women
  • current cigarette smoker (smoked >1 cigarette in the past 7 days)
  • 18 years old or older
  • Willing to consider altering their smoking behavior during their pregnancy
Exclusion Criteria
  • More than 26 weeks' gestation at study entry
  • No telephone access
  • Not planning to live in New England for 1 year
  • Unable to read and speak English

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Biochemically-validated 7-day point prevalence tobacco abstinence at end of pregnancy
Secondary Outcome Measures
NameTimeMethod
Biochemically-validated 7-day point prevalence tobacco abstinence at 3 months postpartum
Self-reported significant (>50%) reduction in tobacco use
Quit attempt of >24 hours duration from enrollment to end of pregnancy

Trial Locations

Locations (2)

Tufts Health Plan

🇺🇸

Waltham, Massachusetts, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath